Immune regulation of Chidamide-induced Linc01010 accumulation in breast cancer cell death

Table 1 The primers used are summarized

Gene name	Primer orientation	Sequence
Lin01010	Forward	5’-GCAAACTTGAGGAATGGGCA-3’
	Reverse	5’-GCCTTGGCTTGCCTATTACC-3’
PD-1	Forward	5’-AGGATGGACACTGCTCTTGG-3’
	Reverse	5’-CTTCTCCTGAGGAAATGCGC-3’
PD-L1	Forward	5’-GGAAATTCCGGCAGTGTACC-3’
	Reverse	5’-GGCATTCAAGGGTTCAAGCA-3’
PD-L2	Forward	5’-ACAGCCAGTTTGCAAAAGGT-3’
	Reverse	5’-TTGGTACTGTCCTTCGTCCC-3’
MKK6	Forward	5’-TTGGAGTCTGGGCATCACGA-3’
	Reverse	5’-GTTGTGGCGATGGCTCCTCT-3’
STAT1	Forward	5’-CCAATGGAACTTGATGGCCC-3’
	Reverse	5’-ACCTCGTCAAACTCCTCAGG-3’
STAT3	Forward	5’-AGTTCTCCTCCACCACCAAG-3’
	Reverse	5’-CCTTGCCAGCCATGTTTTCT-3’
P38	Forward	5’-AGAATGTGCCAGGGGTGTG-3’
	Reverse	5’-GTGGGGTTGCAGAAGTTCAG-3’
GAPDH	Forward	5’-GAGTCAACGGATTTGGTCGT-3’
	Reverse	5’-GACAAGCTTCCCGTTCTCAG-3’

Table 2 The primers used for subcloned Linc01010 exons fragments are summarized

Gene name	Primer orientation	Sequence
Lin01010 E1	Forward	5’-GGATCTGTAGTTCTAGCCTCA-3’
	Reverse	5’-AGTCCTCCTGATTTTCATTCCA-3’
Lin01010 E2	Forward	5’-GCTGGAGTGCAGTGGTGCAC-3’
	Reverse	5’-CTTGGAAAGGTCAGACTTGA-3’
Lin01010 E3	Forward	5’-GGTCTCACTCTGTCACCCAG-3’
	Reverse	5’-CTGTAGTCCCAGCTACTCAG-3’
Lin01010 E4	Forward	5’-GAATAGACTGGCTTCGGGGA-3’
	Reverse	5’-CTGTTGCTGAAGAAGGCGTT-3’
Lin01010 E4-1	Forward	5’-GAATAGACTGGCTTCGGGGA-3’
	Reverse	5’-TCTTTCCCCGATTCCTCAGG-3’
Lin01010 E4-2	Forward	5’-GGGAGGTCAGGGCAGTATTT-3’
	Reverse	5’-ACCAGAGATGGCAGAACTTGA-3’
Lin01010 E4-3	Forward	5’-AGAATGTGCCAGGGGTGTG-3’
	Reverse	5’-CTGTTGCTGAAGAAGGCGTT-3’